Royalty Pharma: Massive Opportunity Ahead
Royalty Pharma(RPRX) Seeking Alpha·2024-11-09 05:46This week, Royalty Pharma plc (NASDAQ: RPRX ) announced Q3 results in line with expectations and modestly raised its 2024 outlook (the third time in a row). The outlook increase of $37.5 million at the midpoint reflects solid portfolio performance, and overall, our teamBuy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter ...